Glaxosmithkline Con Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAXOSMITHKLINE CON, and what generic and branded alternatives to GLAXOSMITHKLINE CON drugs are available?
GLAXOSMITHKLINE CON has two approved drugs.
Summary for Glaxosmithkline Con
US Patents: | 0 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 2 |
PTAB Cases with Glaxosmithkline Con as petitioner: | See PTAB cases with Glaxosmithkline Con as petitioner |
Drugs and US Patents for Glaxosmithkline Con
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline Cons | THRIVE | nicotine polacrilex | GUM, CHEWING;BUCCAL | 077658-001 | Jun 19, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Glaxosmithkline Cons | THRIVE | nicotine polacrilex | GUM, CHEWING;BUCCAL | 077656-001 | Jun 19, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.